If you would like information on the GLUTEN or LACTOSE content of Aspen medications please click here to download a PDF reference sheetCompany Overview
Aspen Pharmacare Australia commenced operations in May 2001 with a portfolio of products generating sales of $10.5 million. Current annualised sales are around $180 million and growing.
At the same time Aspen Pharmacare began distribution of a selected product range in New Zealand. Currently Aspen products are distributed in New Zealand by Healthcare Logistics who also host the Aspen NZ Sales & Marketing teams in their Auckland offices. The available product mix ranges across Ethical, OTC and Grocery with the key brands in those areas being Redipred, Span-K, Chlorvescent, Zincaps, Clear Eyes eye-drops and Cool Charm deodorant.
Sales and Marketing is done in New Zealand by a New Zealand based Product Manager and Aspen use a New Zealand based advertising agency inline with our policy of using local people and local resources in the local economies where possible.
Australian Strategic Partnerships: Our partners and licensors include the biggest names in the pharmaceutical industry, including CSL, Sanofi-Aventis, GlaxoSmithKline, Novartis, Eli Lilly and many others. |
We have a pipeline of products from our South African parent which we plan to launch in Australia and New Zealand.
We have a results-driven and experienced in-house field force for doctors, specialists and hospitals, and an outsourced field force for pharmacy and grocery.
We have an experienced, successful and proven management team.
The company has 2 divisions: OTC/Grocery and Ethicals, as well as a thriving export business.
We are specialists in turning around declining products and we have proven success in product life-cycle management. We revitalise brands through innovative marketing and superlative customer service.
Our product portfolio includes some of the most prescribed brands in Australia and New Zealand, and Aspen Pharmacare Australia is ranked among the top 10 in Australia in terms of prescriptions written for our products (source: IMS).
Company Strategy
Aspen Pharmacare is an entrepreneurial driven company which seeks to identify and bring to market drugs in specialist areas that are overlooked by the multinational pharmaceutical industry. We often work in partnership with other companies, including the multinationals.
Our emphasis is more on brand building and marketing a product on its merits rather than selling on price and discounts.
Unlike other companies which focus on selected therapeutic areas, or generic companies which are focused on being first to market off-patent drugs, our focus is on niche products in niche markets. Our objective is to build a product portfolio where we are able to achieve market growth through our promotional initiatives rather than necessarily having a comprehensive range for all ailments or on having the cheapest drugs in the market.
Company Philosophy
We aim to have a company culture where all employees are valued and treated with respect, and working in concert to achieve company goals.
We see opportunities in products that others may look to divest for reasons of post-merger focus, regulatory issues or lack of financial viability.
We respond quickly to our customers and to market conditions and we make quick, but considered, decisions. While others pay lip-service to customer service, we genuinely believe that the customer is paramount.
